BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 31889370)

  • 21. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
    Sun MY; Wang L; Shen ZY
    Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
    Chi H
    Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line.
    Qiu Y; Li C; Wang Q; Zeng X; Ji P
    Cancer Med; 2018 Feb; 7(2):397-407. PubMed ID: 29316373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma.
    Yang Y; Chen D; Liu H; Yang K
    Cell Death Dis; 2019 Jan; 10(2):41. PubMed ID: 30674868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
    Liu M; Gao X; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
    Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
    J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
    Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
    Zhang X; Liu N; Ma D; Liu L; Jiang L; Zhou Y; Zeng X; Li J; Chen Q
    Int J Oncol; 2016 Aug; 49(2):539-48. PubMed ID: 27279145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.
    Jiang X; Wang J; Chen X; Hong Y; Wu T; Chen X; Xia J; Cheng B
    Oncotarget; 2016 Mar; 7(13):16262-72. PubMed ID: 26919103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway.
    Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W
    Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213575
    [No Abstract]   [Full Text] [Related]  

  • 33. Exploration of pro-apoptotic effect of Thymoquinone on oral squamous cell carcinoma cells through PI3K/Akt signaling pathway.
    Ren X; Luo W
    Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):61-64. PubMed ID: 30782296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galectin‑3 blockade suppresses the growth of cetuximab‑resistant human oral squamous cell carcinoma.
    Yin P; Cui S; Liao X; Yao X
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
    Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
    Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
    Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
    Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
    He W; Lai R; Lin Q; Huang Y; Wang L
    J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naphtho[1,2-b]furan-4,5-dione induces apoptosis of oral squamous cell carcinoma: involvement of EGF receptor/PI3K/Akt signaling pathway.
    Chien CM; Lin KL; Su JC; Chuang PW; Tseng CH; Chen YL; Chang LS; Lin SR
    Eur J Pharmacol; 2010 Jun; 636(1-3):52-8. PubMed ID: 20371243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CircRNA_002178 promotes the proliferation and migration of oral squamous cell carcinoma cells by activating the Akt/mTOR pathway.
    Yang Y; Ci HS; Mao YL; Li JW; Zuo JH
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6122-6130. PubMed ID: 32572877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-378-3p/5p represses proliferation and induces apoptosis of oral squamous carcinoma cells via targeting KLK4.
    Cui Z; Bao X; Liu Q; Li Q; Huang L; Wang H; Jiao K
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):713-724. PubMed ID: 31868942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.